Drug_ID,Drug,Y
"Chlorophenylpiperazine, m-",Clc1cccc(N2CC[NH2+]CC2)c1,2.5
Ortataxel,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C23OC(=O)OC2C(OC(=O)C(O)C(CC(C)C)NC(=O)OC(C)(C)C)C(C)=C1C3(C)C,13.83
Finasteride,CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C,1.1
Trazodone,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,0.52
Demethylchlortetracycline,C[NH+](C)C1C([O-])=C(C(N)=O)C(=O)C2(O)C([O-])=C3C(=O)c4c(O)ccc(Cl)c4C(O)C3CC12,1.3
Tigecycline,CN(C)c1cc(NC(=O)C[NH2+]C(C)(C)C)c(O)c2c1CC1CC3C([NH+](C)C)C([O-])=C(C(N)=O)C(=O)C3(O)C(O)=C1C2=O,12.0
Oxytetracycline,C[NH+](C)C1C([O-])=C(C(N)=O)C(=O)C2(O)C(O)=C3C(=O)c4c(O)cccc4C(C)(O)C3C(O)C12,1.7
Tetracycline,C[NH+](C)C1C([O-])=C(C(N)=O)C(=O)C2(O)C(O)=C3C(=O)c4c(O)cccc4C(C)(O)C3CC12,1.2
Doxycycline,CC1c2cccc(O)c2C(=O)C2=C(O)C3(O)C(=O)C(C(N)=O)=C([O-])C([NH+](C)C)C3C(O)C21,0.69
Minocycline,CN(C)c1ccc(O)c2c1CC1CC3C([NH+](C)C)C([O-])=C(C(N)=O)C(=O)C3(O)C(O)=C1C2=O,1.6
Chlortetracycline,C[NH+](C)C1C([O-])=C(C(N)=O)C(=O)C2(O)C([O-])=C3C(=O)c4c(O)ccc(Cl)c4C(C)(O)C3CC12,0.9
Bepridil,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)[NH+]1CCCC1,10.1
Diprophylline,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,0.42
Pentoxifylline,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,1.8
Caffeine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,0.63
Susalimod,Cc1cccnc1NS(=O)(=O)c1ccc(C#Cc2ccc(O)c(C(=O)[O-])c2)cc1,0.1
Milnacipran,CCN(CC)C(=O)C1(c2ccccc2)CC1C[NH3+],4.51
Carzelesin,CCN(CC)c1ccc2cc(C(=O)Nc3ccc4[nH]c(C(=O)N5CC(CCl)c6c5cc(OC(=O)Nc5ccccc5)c5[nH]cc(C)c65)cc4c3)oc2c1,0.09
Oxymatrine,O=C1CCCC2C3CCC[N+]4([O-])CCCC(CN12)C34,0.61
Chlordiazepoxide,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,0.25
Biperiden,OC(CC[NH+]1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,12.0
Procyclidine,OC(CC[NH+]1CCCC1)(c1ccccc1)C1CCCCC1,0.74
Hydroflumethiazide,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,2.2
Telmisartan,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)[O-])cc1,5.3
Binodenoson,Nc1nc(N[NH+]=CC2CCCCC2)nc2c1ncn2C1OC(CO)C(O)C1O,0.4
Fosphenytoin,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)([O-])[O-],0.06
Roquinimex,CN(C(=O)c1c([O-])c2ccccc2n(C)c1=O)c1ccccc1,0.21
Flupirtine,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)[nH+]c1N,1.1
NBI-3,CC(C1=C(CC[NH+](C)[14CH3])Cc2ccccc21)c1cnccn1,1.86
Glibornuride,Cc1ccc(S(=O)(=O)NC(=O)N[C@H]2[C@H]3CC[C@@](C)([C@H]2O)C3(C)C)cc1,0.27
Candesartan,CCOc1nc2cccc(C(=O)[O-])c2n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1,0.13
Diclofenac,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl,0.22
Nafarelin,CC(C)CC(NC(=O)C(Cc1ccc2ccccc2c1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCNC(N)=[NH2+])C(=O)N1CCCC1C(=O)NCC(N)=O,0.14
Nitrofurantoin,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)[N-]1,0.57
BB 83698,CC(C)(C)C(NC(=O)C(CC1CCCC1)CN(O)C=O)C(=O)N1CCN(Cc2ccc3c(c2)OCO3)CC1,1.1
Fludarabine,Nc1nc(F)nc2c1ncn2C1OC(CO)C(O)C1O,2.2
Cladribine,Nc1nc(Cl)nc2c1ncn2C1CC(O)C(CO)O1,7.7
Clofarabine,Nc1nc(Cl)nc2c1ncn2C1OC(CO)C(O)C1F,1.75
Nelarabine,COc1nc(N)nc2c1ncn2C1OC(CO)C(O)C1O,4.9
Cangrelor,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2C1OC(COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])C(O)C1O,0.04
Pelrinone,Cc1nc(=O)c(C#N)c(NCc2cccnc2)[nH]1,0.39
Pazufloxacin,CC1COc2c(C3([NH3+])CC3)c(F)cc3c(=O)c(C(=O)[O-])cn1c23,0.68
GPX-150,COc1cccc2c1C(=N)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,15.45
Pramipexole,CCC[NH2+]C1CCc2nc(N)sc2C1,7.0
Tolvaptan,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,0.5
Azithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(O)CC(C)C[NH+](C)C(C)C(O)C1(C)O,33.0
Oxacillin,Cc1onc(-c2ccccc2)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)[O-],0.19
Dicloxacillin,Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)[O-],0.11
Flucloxacillin,Cc1onc(-c2c(F)cccc2Cl)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)[O-],0.19
Hydralazine,N[NH+]=c1[nH]ncc2ccccc12,1.5
Sabeluzole,CN(c1nc2ccccc2s1)C1CC[NH+](CC(O)COc2ccc(F)cc2)CC1,5.5
Lubeluzole,CN(c1nc2ccccc2s1)C1CC[NH+](CC(O)COc2ccc(F)c(F)c2)CC1,2.6
Tinidazole,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,0.59
Ethimizol,CCn1cnc(C(=O)NC)c1C(=O)NC,0.73
Cimetidine,CN/C(=N\CCSCc1nc[nH]c1C)NC#N,1.2
Zoledronic Acid,O=P([O-])([O-])C(O)(Cn1ccnc1)P(=O)([O-])O,0.6
Metronidazole,Cc1ncc([N+](=O)[O-])n1CCO,0.4
Dacarbazine,CN(C)N=Nc1nc[nH]c1C(N)=O,1.2
TH-302,Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-],0.64
SR 4554,O=C(Cn1ccnc1[N+](=O)[O-])NCC(O)C(F)(F)F,0.69
Ornidazole,Cc1ncc([N+](=O)[O-])n1CC(O)CCl,1.16
Terlipressin,NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)C[NH3+])CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCC[NH3+])C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O,0.24
Desmopressin,NC(=[NH2+])NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCCC(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,0.3
Medifoxamine,CN(C)CC(Oc1ccccc1)Oc1ccccc1,2.8
619C89,C[NH+]1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1,15.31
Sipatrigine,C[NH+]1CCN(c2ncc(-c3cc(Cl)cc(Cl)c3Cl)c(N)n2)CC1,24.0
Indoramin,O=C(NC1CC[NH+](CCc2c[nH]c3ccccc23)CC1)c1ccccc1,4.9
Captopril,CC(CS)C(=O)N1CCCC1C(=O)[O-],0.75
Heroin,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)[NH+](C)CCC341,1.31
Morphine,C[NH+]1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,2.3
Codeine,COc1ccc2c3c1OC1C(O)C=CC4C(C2)[NH+](C)CCC341,3.5
Berubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC([NH3+])C(OCc2ccccc2)C(C)O1,48.0
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)[O-])NC(=O)[C@H](CCC(=O)[O-])NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)[O-])NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]1CCCN1C(=O)[C@H]([NH3+])Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)[O-],0.27
Eravacycline,C[NH+](C)C1C([O-])=C(C(N)=O)C(=O)C2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)C[NH+]5CCCC5)cc(F)c4CC3CC12,2.3
Citalopram,C[NH+](C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,12.0
Tazarotene,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,3.55
Chlorthalidone,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,3.9
Patupilone,C/C(=C\c1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1,14.4
Trimetrexate,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,0.77
Volasertib,CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCC([NH+]5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C,80.5
KRN-5500,CCCCCCCCC/C=C/C=C/C(=O)NCC(=O)NC1C(O)C(O)C(Nc2[nH]cnc3ncnc2-3)OC1C(O)CO,0.17
Dimetindene,C[C@H](C1=C(CC[NH+](C)C)Cc2ccccc21)c1ccccn1,2.16
Amygdalin,N#CC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)c1ccccc1,0.21
Atovaquone,O=C1C([O-])=C(C2CCC(c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21,0.6
Thioguanine,Nc1nc2[nH]cnc2c(=S)[nH]1,2.89
"Mercaptopurine, 6-",S=c1[nH]cnc2[nH]cnc12,1.0
Lomitapide,O=C(NC1CC[NH+](CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1,16.3
Articaine,CCC[NH2+]C(C)C(=O)Nc1c(C)csc1C(=O)OC,7.7
Mazapertine,CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1,1.54
Encainide,COc1ccc(C(=O)Nc2ccccc2CCC2CCCC[NH+]2C)cc1,2.2
Nemonoxacin,COc1c(N2CC(C)CC([NH3+])C2)ccc2c(=O)c(C(=O)[O-])cn(C3CC3)c12,1.9
Levoprotiline,C[NH2+]CC(O)CC12CCC(c3ccccc31)c1ccccc12,18.8
Maprotiline,C[NH2+]CCCC12CCC(c3ccccc31)c1ccccc12,45.0
Indisulam,NS(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23)cc1,0.68
Maraviroc,Cc1nnc(C(C)C)n1C1CC2CCC(C1)[NH+]2CCC(NC(=O)C1CCC(F)(F)CC1)c1ccccc1,2.3
Idarubicin,CC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC([NH3+])C(O)C(C)O2)C1)C(=O)c1ccccc1C3=O,38.0
Doxorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC([NH3+])C(O)C(C)O1,22.0
Epirubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC([NH3+])C(O)C(C)O1,45.0
Iododoxorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC([NH3+])C(I)C(C)O1,53.6
Tofacitinib,CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12,1.24
Pitavastatin,O=C([O-])CC(O)CC(O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1,0.9
Nicotine,C[NH+]1CCCC1c1cccnc1,2.6
Naratriptan,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CC[NH+](C)CC3)c2c1,2.4
Almotriptan,C[NH+](C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,2.2
Montelukast,CC(C)(O)c1ccccc1CCC(SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,0.15
Pyrimethamine,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,0.43
Levocabastine,CC1C[NH+](C2CCC(C#N)(c3ccc(F)cc3)CC2)CCC1(C(=O)[O-])c1ccccc1,1.17
Zaleplon,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,1.3
Vancomycin,C[NH2+]C(CC(C)C)C(=O)NC1C(=O)NC(CC(N)=O)C(=O)NC2C(=O)NC3C(=O)NC(C(=O)NC(C(=O)[O-])c4cc(O)cc(O)c4-c4cc3ccc4O)C(O)c3ccc(c(Cl)c3)Oc3cc2cc(c3OC2OC(CO)C(O)C(O)C2OC2CC(C)([NH3+])C(O)C(C)O2)Oc2ccc(cc2Cl)C1O,0.54
Telavancin,CCCCCCCCCC[NH2+]CCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)[NH2+]C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)[O-])c5cc(O)c(C[NH2+]CP(=O)([O-])[O-])c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,0.11
Theophylline,Cn1c(=O)c2nc[nH]c2n(C)c1=O,0.51
Bromotetrandrine,COc1ccc2cc1Oc1ccc(cc1)CC1(C)c3cc(c(OC)cc3CC[NH+]1C)Oc1c(OC)c(OC)c(Br)c3c1C(C)(C2)N(C)CC3,51.0
Tropatepine,C[NH+]1C2CCC1CC(=C1c3ccccc3CSc3ccccc31)C2,11.85
